• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

m6A 调控心肌纤维化中的细胞死亡。

m6A control programmed cell death in cardiac fibrosis.

机构信息

Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, PR China.

Anhui Women and Children's Medical Center, Hefei 230001, PR China.

出版信息

Life Sci. 2024 Sep 15;353:122922. doi: 10.1016/j.lfs.2024.122922. Epub 2024 Jul 18.

DOI:10.1016/j.lfs.2024.122922
PMID:39032691
Abstract

N6-methyladenosine (m6A) modification is closely related to cardiac fibrosis. As the most common and abundant form of mRNA modification in eukaryotes, m6A is deposited by methylases ("writers"), recognized and effected by RNA-binding proteins ("readers"), and removed by demethylases ("erasers"), achieving highly dynamic reversibility. m6A modification is involved in regulating the entire biological process of target RNA, including transcription, processing and splicing, export from the nucleus to the cytoplasm, and enhancement or reduction of stability and translation. Programmed cell death (PCD) comprises many forms and pathways, with apoptosis and autophagy being the most common. Other forms include pyroptosis, ferroptosis, necroptosis, mitochondrial permeability transition (MPT)-dependent necrosis, and parthanatos. In recent years, increasing evidence suggests that m6A modification can mediate PCD, affecting cardiac fibrosis. Since the correlation between some PCD types and m6A modification is not yet clear, this article mainly introduces the relationship between four common PCD types (apoptosis, autophagy, pyroptosis, and ferroptosis) and m6A modification, as well as their role and influence in cardiac fibrosis.

摘要

N6-甲基腺苷(m6A)修饰与心脏纤维化密切相关。作为真核生物中最常见和丰富的 mRNA 修饰形式,m6A 由甲基转移酶(“写入器”)沉积,由 RNA 结合蛋白(“读取器”)识别和作用,并由去甲基酶(“橡皮擦”)去除,实现高度动态的可逆性。m6A 修饰参与调节靶 RNA 的整个生物学过程,包括转录、加工和剪接、从核输出到细胞质、以及增强或降低稳定性和翻译。程序性细胞死亡(PCD)包括多种形式和途径,其中凋亡和自噬最为常见。其他形式包括细胞焦亡、铁死亡、坏死性凋亡、线粒体通透性转换(MPT)依赖性坏死和 Parthanatos。近年来,越来越多的证据表明 m6A 修饰可以介导 PCD,影响心脏纤维化。由于某些 PCD 类型与 m6A 修饰之间的相关性尚不清楚,本文主要介绍了四种常见的 PCD 类型(凋亡、自噬、细胞焦亡和铁死亡)与 m6A 修饰之间的关系,以及它们在心脏纤维化中的作用和影响。

相似文献

1
m6A control programmed cell death in cardiac fibrosis.m6A 调控心肌纤维化中的细胞死亡。
Life Sci. 2024 Sep 15;353:122922. doi: 10.1016/j.lfs.2024.122922. Epub 2024 Jul 18.
2
Insights into N6-methyladenosine and programmed cell death in cancer.N6-甲基腺苷与癌症中的细胞程序性死亡研究进展
Mol Cancer. 2022 Jan 28;21(1):32. doi: 10.1186/s12943-022-01508-w.
3
Novel insights into the interplay between m6A modification and programmed cell death in cancer.新型见解揭示 m6A 修饰与癌症中程序性细胞死亡的相互作用。
Int J Biol Sci. 2023 Mar 13;19(6):1748-1763. doi: 10.7150/ijbs.81000. eCollection 2023.
4
N(6)-methyladenosine modification: A vital role of programmed cell death in myocardial ischemia/reperfusion injury.N(6)-甲基腺苷修饰:细胞程序性死亡在心肌缺血/再灌注损伤中的重要作用。
Int J Cardiol. 2022 Nov 15;367:11-19. doi: 10.1016/j.ijcard.2022.08.042. Epub 2022 Aug 21.
5
mA: An Emerging Role in Programmed Cell Death.毫安:在程序性细胞死亡中的新作用。
Front Cell Dev Biol. 2022 Jan 24;10:817112. doi: 10.3389/fcell.2022.817112. eCollection 2022.
6
N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.N6-甲基腺苷RNA修饰:中枢神经系统损伤中一个有前景的调节因子。
Exp Neurol. 2021 Nov;345:113829. doi: 10.1016/j.expneurol.2021.113829. Epub 2021 Jul 31.
7
Novel Insights into the Links between N6-Methyladenosine and Regulated Cell Death in Musculoskeletal Diseases.骨骼肌疾病中 N6-甲基腺苷与调控细胞死亡关系的新见解
Biomolecules. 2024 Apr 24;14(5):514. doi: 10.3390/biom14050514.
8
Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.哺乳动物配子发生过程中mRNA N6-甲基腺苷修饰的表观遗传调控
Mol Hum Reprod. 2021 May 8;27(5). doi: 10.1093/molehr/gaab025.
9
The regulatory mechanisms of N6-methyladenosine modification in ferroptosis and its implications in disease pathogenesis.N6-甲基腺苷修饰在铁死亡中的调控机制及其在疾病发病机制中的意义。
Life Sci. 2024 Oct 15;355:123011. doi: 10.1016/j.lfs.2024.123011. Epub 2024 Aug 23.
10
Insights into RNA N6-methyladenosine and programmed cell death in atherosclerosis.RNA N6-甲基腺苷与动脉粥样硬化中程序性细胞死亡的研究进展
Mol Med. 2024 Sep 3;30(1):137. doi: 10.1186/s10020-024-00901-z.

引用本文的文献

1
Novel insights into the N 6-methyladenosine modification on circRNA in cancer.对癌症中环状RNA上N6-甲基腺苷修饰的新见解。
Front Oncol. 2025 May 19;15:1554888. doi: 10.3389/fonc.2025.1554888. eCollection 2025.
2
Identification of biomarkers associated with programmed cell death in liver ischemia-reperfusion injury: insights from machine learning frameworks and molecular docking in multiple cohorts.肝缺血再灌注损伤中与程序性细胞死亡相关的生物标志物的鉴定:来自多个队列的机器学习框架和分子对接的见解
Front Med (Lausanne). 2025 Mar 14;12:1501467. doi: 10.3389/fmed.2025.1501467. eCollection 2025.
3
The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases.
m6A与程序性细胞死亡在心血管疾病中的新兴作用
Biomolecules. 2025 Feb 8;15(2):247. doi: 10.3390/biom15020247.
4
Regulatory mechanisms of mA methylation in dilated cardiomyopathy.扩张型心肌病中 mA 甲基化的调控机制
Am J Transl Res. 2025 Jan 15;17(1):47-59. doi: 10.62347/AOSK8903. eCollection 2025.